EP1996710
Rifaximín samsetning gegn endaþarmssjúkdómum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
6.3.2007EP published:
14.8.2019EP application number:
07752538.4
EP translation filed:
6.9.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
5.3.2027
Title:
RIFAXIMIN ANTI-RECTAL DYSFUNCTION PREPARATION
Timeline
Today
6.3.2007EP application
14.8.2019EP Publication
6.9.2019Translation submitted
15.9.2019Registration published
Owner
Name:
Salix Pharmaceuticals, Inc.Address:
1700 Perimeter Park Drive, 27560, Morrisville, NC, US
Name:
Safdi, AlanAddress:
2925 Vernon Place Suite 100, 45219, Cincinnati, OH, US
Inventor
Name:
SAFDI, AlanAddress:
Cincinnati, OH, US
Name:
TAYLOR, DavidAddress:
Dunfermline, Fife KY11 3DU, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
781144 PDate:
9.3.2006Country:
US
Number:
791236 PDate:
11.4.2006Country:
US
Classification
Categories:
A61K 49/00, A61K 9/00, A61K 31/00, A61K 9/02, A61K 45/06, A61K 31/437, A61K 31/21, A61K 31/573